| Structure | Chemical Name | CAS | MF |
|
new type polyurethane catalyst
|
|
|
|
|
New-type special boat hull paint
|
|
|
|
|
New type antifouling coating,longacting
|
|
|
|
|
New type cation softener
|
|
|
|
|
New-type special anticorrosive varnish
|
|
|
|
|
New-type special anticorrosive paint with rust
|
|
|
|
|
neyarthros
|
|
|
|
|
new water borne high build corrosive protective coating
|
|
|
|
|
new water based anti rust paint
|
|
|
|
|
new wall coating
|
|
|
|
|
New yang jan
|
|
|
|
N-(exo-(hexahydro-1H-pyrrolizine-1-yl)methyl)-2-methoxy-4-amino-5-chlorobenzamide
|
146388-57-0
|
|
|
|
NEWYORKESOPHAGEALSQUAMOUSCELLCARCINOMA1,HUMAN,RECOMBINANT
|
|
|
|
|
New York protocol
|
|
|
|
|
NEWZEALANDSPINACHLEAVESEXTRACTS
|
|
|
|
Nexopamil
|
136033-49-3
|
C24H40N2O3
|
|
|
Nex-1 protein
|
|
|
|
|
NGD16-4 protein
|
|
|
|
|
NEX protein
|
|
|
|
|
NextalDwblocks
|
|
|
|
|
NextalStockKitSalt
|
|
|
|
|
NextalStockKitCryo
|
|
|
|
|
NextalStockSolutions
|
|
|
|
|
NextalTubes
|
|
|
|
|
NextalDwblockAdhesiveFoils
|
|
|
|
|
NextalStockKitBuffer
|
|
|
|
N-{(3E,4Z)-2-ACETYL-4-[(2,5-DICHLOROPHENYL)HYDRAZONO]-5-OXOPYRAZOLIDIN-3-YLIDENE}ACETAMIDE
|
|
C13H11Cl2N5O3
|
|
N-{(3E,4Z)-2-ACETYL-4-[(4-CHLOROPHENYL)HYDRAZONO]-5-OXOPYRAZOLIDIN-3-YLIDENE}ACETAMIDE
|
|
C13H12ClN5O3
|
|
|
NFPA labels
|
|
|
|
|
NGF, ANTI-MOUSE (AFFINITY PURIFIED)
|
|
|
|
N-{(3E,4Z)-2-BENZOYL-4-[(2,4-DICHLOROPHENYL)HYDRAZONO]-5-OXOPYRAZOLIDIN-3-YLIDENE}BENZAMIDE
|
|
C23H15Cl2N5O3
|
|
N'-[(1E,2Z)-2-BROMO-3-PHENYLPROP-2-ENYLIDENE]-4-NITROBENZOHYDRAZIDE
|
|
C16H12BrN3O3
|
|
N'-[(1E,2Z,4E)-1-METHYL-5-PHENYLPENTA-2,4-DIENYLIDENE]NICOTINOHYDRAZIDE
|
|
C18H17N3O
|
|
|
NFO protocol
|
|
|
|
|
N-GERANYL-N'-(2-ADAMANTYL)ETHANE-1,2-DIAMINE, SQ109
|
|
|
|
N'-geranylpiperazinylfarnesyl acetamide
|
|
C31H53N3O
|
|
|
NGFI-B protein
|
121479-42-3
|
|
|
|
N(α)-Formyl-DL-Trp-OH
|
|
|
|
N-(2-Formyl-3-methoxypyridin-4-yl)pivalamide
|
1171919-99-5
|
C12H16N2O3
|
|
N-(4-Formyl-2-methoxypyridin-3-yl)pivalamide
|
1142192-44-6
|
C12H16N2O3
|
|
N-(3-Formyl-5-methylpyridin-2-yl)pivalamide
|
127446-31-5
|
C12H16N2O2
|
|
N-(2-Formylfuro[3,2-b]pyridin-7-yl)pivalamide
|
1203499-07-3
|
C13H14N2O3
|
|
N-Formyl-L-leucine (3S,4S,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester
|
130676-65-2
|
C29H53NO5
|
|
N-Formyl N,N-Didesmethyl Sibutramine
|
84467-85-6
|
C16H22ClNO
|
|
N-Formyl-L-leucine-d3
|
|
C7H13NO3
|
|
N-Formyl N,N-Didesmethyl Sibutramine-d6
|
|
C16H22ClNO
|
|
N-[4-[2-(formyloxy)ethyl]phenyl]-
|
14984-13-5
|
C10H11NO3
|
|
N-[4-[2-(formyloxy)ethyl]-2-Nitrophenyl]
|
15788-09-7
|
C10H10N2O5
|
|
|
N-Formyl D-2'-Deoxyribofuranosyl-3-guanylurea
(α/β-Mixture)
|
|
C8H14N4O5
|
|
N-Formyl γ-Carboxyglutamic Acid γ,γ-Di-t-butyl 3-Ethyl Ester
|
75117-30-5
|
C17H29NO7
|
|
N-(6-formylpyridin-3-yl)acetamide
|
|
C8H8N2O2
|
|
N-[(5-formyl-2-furyl)methyl]-N-methylmethanesulfonamide(SALTDATA: FREE)
|
878427-52-2
|
C8H11NO4S
|
|
N-ForMyl Maraviroc
|
|
C30H41F2N5O2
|
|
N-ForMyl Maraviroc-d6
|
|
C30H41F2N5O2
|
|
N-ForMyl-D-ribofuranosyl-3-guanylurea (α/β-Mixture)
|
686299-20-7
|
C8H14N4O6
|
|
N-ForMyl Valacyclovir
|
847670-62-6
|
C14H20N6O5
|
|
N-ForMyl Thyroxine-13C6
|
|
C16H11I4NO5
|
|
N-ForMyl Oxcarbazepine
|
1346601-76-0
|
C16H12N2O3
|
|
N-ForMyl Thyroxine
|
671235-41-9
|
C16H11I4NO5
|
|
N-(3-Formyl-5-(trifluoromethyl)pyridin-2-yl)-pivalamide
|
1261365-46-1
|
C12H13F3N2O2
|
|
N-Formyl-di-(1-isopropylphenyl)amine (N-Formyl DPIA)
|
71685-26-2
|
C19H23NO
|
|
N-(2-ForMaMidoethyl)forMaMid
|
4938-92-5
|
C4H8N2O2
|
|
N-(3-forMyl-4,5-diMethylthiophen-2-yl)acetaMide
|
51948-01-7
|
C9H11NO2S
|
|
N-(3-forMylbenzo[b]thiophen-2-yl)acetaMide
|
74323-01-6
|
C11H9NO2S
|
|
N-Formyl-N-phosphonomethylglycine
|
84767-96-4
|
C4H8NO6P
|
|
N-Formyl-2-methoxy-2-methyl-propylamine
|
112129-25-6
|
C6H13NO2
|
|
|
N- forMyl valaciclovir
|
|
|
|
N-ForMylMorpholine-13C
|
113009-82-8
|
C5H9NO2
|
|
N-ForMyl-L-leucine [S-(E)]-1-(2-Nonenyl)dodecyl Ester
|
130676-63-0
|
C28H53NO3
|
|
N-ForMyl-L-isoleucine (1S)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]Methyl]dodecyl Ester
|
1072902-75-0
|
C29H53NO5
|
|
(R,R,S,S)-Orlistat
|
1225451-00-2
|
C29H53NO5
|
|
N-[(3α,5β,7α)-7-(ForMyloxy)-3-hydroxy-24-oxocholan-24-yl]-glycine Ethyl Ester
|
|
C29H47NO6
|
|
(+)-N-ForMyl-3-(Methoxy-d3)Morphinan
|
|
C18H20D3NO2
|
|
N-ForMyl-
|
104872-27-7
|
C29H53NO5
|
|
N-(4-forMyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)MethanesulfonaMide
|
1351277-22-9
|
C13H19BN2O5S
|
|
N-(5-forMylpyridin-2-yl)acetaMide
|
149141-11-7
|
C8H8N2O2
|
|
N-(5-forMyl-3-Methylpyridin-2-yl)MethanesulfonaMide
|
1289162-29-3
|
C8H10N2O3S
|
|
N-(6-forMylpyridin-2-yl)acetaMide
|
127682-66-0
|
C8H8N2O2
|
|
N-ForMyl-D-leucine, tech. 90%
|
44978-39-4
|
C7H13NO3
|
|
N-ForMylsaccharin
|
50978-45-5
|
C8H5NO4S
|
|
N-ForMyl Desloratadine
|
117810-61-4
|
C20H19ClN2O
|
|
6-(N-FORMYLAMINO)HEXANOIC ACID
|
|
C7H13NO3
|
|
N-(2-FORMYLPHENYL)-3-NITROBENZAMIDE
|
192377-32-5
|
C14H10N2O4
|
|
N-(6-formyl-4-oxo-1H-pteridin-2-yl)acetamide
|
29769-49-1
|
C9H7N5O3
|
|
N-(2-FORMYL-PHENYL)-ACETAMIDE
|
|
C9H9NO2
|
|
N-FORMYL-L-LEUCINE
|
6113-61-7
|
C7H13NO3
|
|
N-Formyl-3,4-di-tert-butoxycarbonyloxy-6-(trimethylstannyl)-D-phenylalanine ethyl ester
|
|
C25H39NO9Sn
|
|
N-Formyl-3,4-di-tert-butoxycarbonyloxy-6-(trimethylstannyl)-phenylalanine ethyl ester
|
|
C25H39NO9Sn
|
|
N-FORMYL-NLE-LEU-PHE-TYR
|
100007-40-7
|
C31H42N4O7
|
|
N-Formylhexamethyleneimine
|
|
C7H13NO
|
|
N-Formyl-5-asa
|
104786-99-4
|
C8H7NO4
|
|
N-Formyl-4-(methylamino)benzoic acid
|
51865-84-0
|
C9H9NO3
|
|
N-Formyl isonipectoic acid
|
|
C7H11NO3
|
|
N-FORMYL-METHIONINE P-NITROANILIDE
|
102185-40-0
|
C12H15N3O4S
|
|
N-formylmethionyl-leucyl-phenylalanyl-tyrosine
|
|
C30H40N4O7S
|
|
N-(6-FORMYLPYRIDIN-2-YL)PIVALAMIDE
|
372948-82-8
|
C11H14N2O2
|
|
N-formylglutathione
|
70239-28-0
|
|
|
N-FORMYL-4-PIPECOLINE
|
21968-26-3
|
C7H13NO
|
|
N-formylmethionyl-leucyl-tyrosine
|
97521-28-3
|
C21H31N3O6S
|
|
N-FORMYLNITROPHENYLHYDROXAMICACID
|
|
C8H6N2O5
|